Litcius/Paper detail

Metastasis-Free Survival Versus Treatment-Free Survival in Biochemically Recurrent Prostate Cancer: The EMBARK Trial

David J. Einstein, Meredith M. Regan, Julia S. Stevens, David F. McDermott, Ravi A. Madan

2024Journal of Clinical Oncology16 citationsDOIOpen Access PDF

Abstract

What is most important to patients with BCR prostate cancer? Metastasis-free versus treatment-free survival.

Topics & Concepts

MedicineProstate cancerMetastasisOncologyOverall survivalCancerProgression-free survivalInternal medicineProstateBiochemical recurrenceProstatectomyProstate Cancer Treatment and ResearchProstate Cancer Diagnosis and TreatmentCancer, Lipids, and Metabolism
Metastasis-Free Survival Versus Treatment-Free Survival in Biochemically Recurrent Prostate Cancer: The EMBARK Trial | Litcius